Yuan-An Liu
Director, Protein & Adc Drug Product BioNTech
Yuan-An (Angus) Liu holds a PhD in Chemical Engineering. He is working as Director Protein & ADC Drug Product in Global Technical Development of BioNTech SE. He has been leading late-stage drug products and process development for small molecules and biologics and is now dedicated to antibody-drug conjugates (ADCs). He is working on developing effective and safe ADC drug products for treating patients with cancers, which covers the design of drug products, formulation, process development and support to clinical administrations. His technical expertise lies in aseptic processing units including sterilizing filtration, aseptic filling and lyophilization.
Seminars
- The challenges in the final steps of aseptic manufacturing of ADC drug product (DP) has shared less spotlight
- Outlining technical challenges in ADC DP manufacturing, for example, the highly potent/cytotoxic payload necessitates containment strategies to protect operators and environment; in most cases, ADCs need to be lyophilized due to their poor liquid stability; light exposure controls are often implemented to overcome restricted photostability
- Discussing the impacts from these challenges on DP process development, validation, manufacturing, and mitigations proposed to reduce risks